A bispecific glycopeptide spatiotemporally regulates tumor microenvironment for inhibiting bladder cancer recurrence

Up to 75% of bladder cancer patients suffer from recurrence due to postoperative tumor implantation. However, clinically used Bacillus Calmette-Guerin (BCG) treatment failed to inhibit the recurrence. Here, we report a bispecific glycopeptide (bsGP) that simultaneously targets CD206 on tumor-associa...

Descripción completa

Detalles Bibliográficos
Autores principales: An, Hong-Wei, Hou, Da-Yong, Yang, Jia, Wang, Zi-Qi, Wang, Man-Di, Zheng, Rui, Zhang, Ni-Yuan, Hu, Xing-Jie, Wang, Zhi-Jia, Wang, Lu, Liu, Di, Hao, Jun-Feng, Xu, Wanhai, Zhao, Yuliang, Wang, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2023
Materias:
Biomedicine and Life Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977173/
https://www.ncbi.nlm.nih.gov/pubmed/36857458
http://dx.doi.org/10.1126/sciadv.abq8225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977173/
https://www.ncbi.nlm.nih.gov/pubmed/36857458
http://dx.doi.org/10.1126/sciadv.abq8225

Ejemplares similares